Sanofi (France)
Parent Company
174/180 Avenue de France
Paris
Cedex
75013
France
Tel: 33-1-53-77-4000
Website: http://www.sanofi-synthelabo.fr/
2154 articles about Sanofi (France)
-
Sanofi-Aventis (France) Release: New Clinical Data Show Enoxaparin Significantly Reduced The Risk Of Repeat Heart Attack And Stroke Iin Patients Undergoing Percutaneous Coronary Intervention (PCI)
9/5/2006
-
Avantium Technologies Provides Crystal16(TM) To All Research Sites Of Sanofi-Aventis (France)
9/5/2006
-
The Day In Review: Bristol-Myers Squibb Company Gets Injunction Against Generic Plavix
9/1/2006
-
Sanofi-Aventis (France) And Bristol-Myers Squibb Company Release: Preliminary Injunction Ordered In Plavix(R) Patent Infringement Case; Apotex Inc. To Halt Sales Of Unauthorized Generic
9/1/2006
-
Sanofi-Aventis (France) Gets Non-Approvable Letter From US FDA For Dronedarone
8/31/2006
-
ImmunoGen, Inc. Announces Sanofi-Aventis (France) Extendeds The Term Of Its Research Collaboration With The Company; Immunogen Gets $10 Million More
8/31/2006
-
FDA Approves New Indication For PLAVIX(R) (clopidogrel bisulfate) Offering New Option For Patients With Most Severe Type Of Heart Attack
8/17/2006
-
The Day In Review: Neurochem, Inc. Climbs On Approvable Letter
8/14/2006
-
Small Firm Figures Big In War Of Drug Giants
8/14/2006
-
Sanofi-Aventis (France) Release: The FDA Approves Actonel For Broader Use In Men With Osteoporosis
8/14/2006
-
Bristol-Myers Squibb Company Release: Motion Filed For Preliminary Injunction In PLAVIX(R) Patent Infringement Case
8/14/2006
-
Generic Drug Maker Apotex Inc. Launches Plavix Clone Without Legal Clearance
8/8/2006
-
Sanofi-Aventis (France) Announces First Half Of 2006: Sales Growth Of 7.7% On A Reported Basis And 4.5% On A Comparable Basis(1) Adjusted EPS(1) Growth Of 32.9%, Or 16.1% Excluding Selected Items(3)
8/2/2006
-
Sanofi-Aventis (France) And Bristol-Myers Squibb Company Release: PLAVIX(R) Litigation Settlement Fails To Receive Antitrust Clearance From States Attorneys General
7/31/2006
-
Sanofi-Aventis (France): Release Of First Half 2006 Sales & Earnings - Wednesday August 2, 2006
7/21/2006
-
Taiho Pharmaceutical And Sanofi-Aventis (France) Conclude Licensing Agreement For Oral Pyrimidine Fluoride-Derived Anticancer Agent TS-1
7/10/2006
-
Novozymes, Inc. Acquires Delta Biotechnology, Ltd.; New company To Operate Under The Name Novozymes Delta Ltd.
7/7/2006
-
U.S. Warns Sanofi-Aventis (France) Over Flu Shot Plant Problems
7/5/2006
-
The Day In Review: Sanofi-Aventis (France) In-Licenses Japanese Cancer Drug
7/5/2006
-
Sanofi-Aventis (France) To Pay $360 Million To Japan's Taiho Pharmaceutical To License S-1 Oral Anticancer Agent
7/5/2006